FBLN5 and cancer: A recent study showed that fibulin-5 is downregulated in human endometrial cancer and that fibulin-5 knockdown in endometrial epithelial cancer cells enhances adhesion and proliferation of cancer cells, indicating its antitumorigenic role in women [121].